MYOS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MYOS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Myos Rens Technology's yield on cost for the quarter that ended in Sep. 2020 was 0.00.
The historical rank and industry rank for Myos Rens Technology's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Drug Manufacturers - Specialty & Generic subindustry, Myos Rens Technology's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Myos Rens Technology's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Myos Rens Technology's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Myos Rens Technology is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
Myos Rens Technology (NAS:MYOS) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of Myos Rens Technology's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Joseph Mannello | director, officer: Chief Executive Officer | C/O BREAN CAPITAL, LLC, 1345 AVENUE OF THE AMERICAS, 29TH FLOOR, NEW YORK NY 10105 |
Victor E Mandel | director | PO BOX 5962, WASHINGTON DC 20016 |
Robert J Hariri | director | 341 MENDHAM ROAD, BERNARDSVILLE NJ 07924 |
Christopher Pechock | director | C/O MATLINPATTERSON GLOBAL ADVISORS INC, 520 MADISON AVE, NEW YORK NY 10022-4213 |
Christopher C Dewey | director | 120 BROADWAY, 27TH FLOOR, NEW YORK NY 10271 |
Louis J. Aronne | director | 4640 ADMIRALTY, SUITE 500, MARINA DEL RAY CA 90292 |
Eric Zaltas | director | 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ 07927 |
Andrew Joel Ponte | director | 45 HORSEHILL ROAD, SUITE 106, CEDAR KNOLLS NJ 07927 |
David J Matlin | 10 percent owner | |
John Nosta | director | 45 HORSEHILL ROAD, SUITE 106, CEDAR KNOLLS NJ 07927 |
Zhengguang Lyu | director | 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019 |
Ren Ren | director, 10 percent owner | 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019 |
Rens Technology Inc | 10 percent owner | 150 DRAKE STREET ROOM 7F, POMONA CA 91767 |
Rens Agriculture Science & Technology Co, Ltd | 10 percent owner | 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019 |
Guiying Zhao | director | 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING F4 210019 |
From GuruFocus
By [email protected] [email protected] • 12-17-2019
By PRNewswire PRNewswire • 11-17-2020
By PRNewswire PRNewswire • 12-10-2019
By PRNewswire PRNewswire • 07-25-2020
By PRNewswire PRNewswire • 03-19-2020
By PRNewswire PRNewswire • 06-04-2020
By PRNewswire PRNewswire • 01-30-2020
By [email protected] insider • 03-09-2020
By PRNewswire PRNewswire • 03-10-2020
By PRNewswire PRNewswire • 09-09-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.